Andriy Bazylevych, A Bazylevych, A Bazilevich, A Bazilevych, Андрій Базилевич, А Базилевич, A
Andriy Bazylevych, A Bazylevych, A Bazilevich, A Bazilevych, Андрій Базилевич, А Базилевич, A
Підтверджена електронна адреса в meduniv.lviv.ua
Назва
Посилання
Посилання
Рік
Apixaban versus warfarin in patients with atrial fibrillation
CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ...
New England Journal of Medicine 365 (11), 981-992, 2011
83672011
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
41352013
Eplerenone in patients with systolic heart failure and mild symptoms
F Zannad, JJV McMurray, H Krum, DJ van Veldhuisen, K Swedberg, H Shi, ...
New England Journal of Medicine 364 (1), 11-21, 2011
27712011
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
K Swedberg, M Komajda, M Böhm, JS Borer, I Ford, A Dubost-Brama, ...
The Lancet 376 (9744), 875-885, 2010
26102010
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ...
New England Journal of Medicine 369 (14), 1327-1335, 2013
25542013
Long-term use of ticagrelor in patients with prior myocardial infarction
MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ...
New England Journal of Medicine 372 (19), 1791-1800, 2015
15582015
Rivaroxaban with or without aspirin in stable cardiovascular disease
JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ...
New England Journal of Medicine 377 (14), 1319-1330, 2017
13182017
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
K Fox, I Ford, PG Steg, M Tendera, R Ferrari, B Investigators, ...
The Lancet 372 (9641), 807-816, 2008
13042008
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
C Vogelmeier, B Hederer, T Glaab, H Schmidt, MPMH Rutten-van Mölken, ...
New England Journal of Medicine 364 (12), 1093-1103, 2011
8472011
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...
The Lancet 391 (10117), 219-229, 2018
5162018
Ivabradine in stable coronary artery disease without clinical heart failure
K Fox, I Ford, PG Steg, JC Tardif, M Tendera, R Ferrari, SIGNIFY, ...
New England Journal of Medicine 371 (12), 1091-1099, 2014
4822014
Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial
JC Tardif, P Ponikowski, T Kahan, ASSOCIATE, study Investigators, ...
European Heart Journal 5 (30), 540–548, 2009
4702009
Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized …
M Jadzinsky, A Pfützner, E Paz‐Pacheco, Z Xu, E Allen, R Chen, ...
Diabetes, Obesity and Metabolism 11 (6), 611-622, 2009
3632009
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
JD Easton, RD Lopes, MC Bahit, DM Wojdyla, CB Granger, L Wallentin, ...
The Lancet Neurology 11 (6), 503-511, 2012
3052012
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ...
The Lancet 391 (10117), 205-218, 2018
2482018
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner Z, Rydén L ...
Atherosclerosis 285, 135-146, 2019
942019
The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction–baseline characteristics of the …
VM Maria da Consolação, S Heringer-Walther, N Wessel, TM Ventura, ...
Cardiology 110 (4), 271-282, 2008
802008
Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme …
K Kotseva, G De Backer, D De Bacquer, L Rydén, A Hoes, D Grobbee, ...
European Journal of Preventive Cardiology, 2047487320908698, 2020
202020
Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A …
RL Ferrannini G, de Bacquer D, De Backer G, Kotseva K, Mellbin L, Wood D
Diabetes Care 43 (4), 726-733, 2020
192020
Effects of the lercanidipine–enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database
G Mancia, S Omboni, I Chazova, A Coca, X Girerd, H Haller, G Parati, ...
Journal of hypertension 34 (1), 139-148, 2016
182016
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20